WhatDoTheyPrescribe.com is an educational resource explaining real-world prescribing patterns and is not a substitute for professional medical advice.

What do they prescribe?

Specify State (optional)

Search by Prescriber

Search by Drug

Doctors Who Prescribe Aripiprazole (Opipza, Abilify) in District of Columbia

Also known as: Opipza, Abilify

Find doctors, physicians, and healthcare providers who prescribe Aripiprazole in District of Columbia. This page lists the top prescribers of Aripiprazole based on Medicare Part D data, including the number of claims, patients served, and total drug costs.

What is Aripiprazole?

Aripiprazole is indicated for the treatment of: • Schizophrenia • Irritability Associated with Autistic Disorder • Treatment of Tourette’s Disorder Aripiprazole is an atypical antipsychotic. The oral formulations are indicated for: • Schizophrenia (14.1) • Irritability Associated with Autistic Disorder (14.4) • Treatment of Tourette’s disorder (14. It belongs to a class of drugs known as atypical antipsychotic.

Total Claims in District of Columbia
5,767
0.2% of all Aripiprazole prescriptions nationwide
Total Beneficiaries in District of Columbia
507
Total Cost in District of Columbia
$3,148,093

Top Prescribers in DC(0+)

Specify State (optional)

PrescriberLocationTypeClaimsBeneficiariesCost
Loading more data in background...

Find Aripiprazole doctors in other states

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services.
Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.